Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis
Open Access
- 30 October 2019
- journal article
- research article
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 312 (6) , 453-458
Abstract
Systemic sclerosis (SSc) is a chronic connective tissue disease characterized by progressive fibrosis, vascular impairment and immune abnormalities. In recent years, adipokines (mediators synthetized by adipose tissue) have been indicated as a possible missing link in the pathogenesis of SSc. The aim of this study was to investigate the serum concentration of metabolic adipose tissue factors: adiponectin, resistin, leptin and endothelial proteins: endothelin-1, fractalkine and galectin-3 in patients with systemic sclerosis. The study included 100 patients with confirmed SSc diagnosis and 20 healthy individuals. The concentration of respective proteins was determined by enzyme-linked immunosorbent assay. The following markers showed statistically significant increased mean concentrations in patients with SSc in comparison to healthy control: resistin (13.41 vs 8.54 ng/mL; P = 0.0012), endothelin-1 (1.99 vs 1.31 pg/mL; P = 0.0072) and fractalkine (2.93 vs 1.68 ng/mL; P = 0.0007). Elevated serum levels of galectin-3 (4.54 vs 3.26 ng/mL; P = 0.0672) and leptin (19,542 vs 14,210 pg/mL; P = 0.1817) were observed. Decreased concentration of adiponectin was found in patients with SSc (5150 vs 8847 pg/mL; P = 0.0001). Fractalkine and galectin-3 levels were significantly higher in diffuse cutaneous SSc than limited cutaneous SSc subset (3.93 ng/mL vs 2.58 ng/mL, P = 0.0018; 6.86 ng/mL vs 3.78 ng/mL, P = 0.0008, respectively) and correlated positively with modified Rodnan Skin Score in total SSc patients (r = 0.376, P = 0.0009; r = 0.236, P = 0.018, respectively). In conclusion, an increased serum level of resistin associated with increased endothelin-1 and fractalkine level and decreased adiponectin level may indicate a significant role of the adipose tissue in the development and progression of vascular abnormalities in patients with systemic sclerosis. Fractalkine and galectin-3 may participate in promoting and exacerbating the fibrotic process in SSc.Keywords
Funding Information
- Warszawski Uniwersytet Medyczny (1M4/N/19/19)
This publication has 28 references indexed in Scilit:
- Galectin-3 is an independent predictor of survival in systemic sclerosisInternational Journal of Cardiology, 2017
- Endothelial cell‐derived endothelin‐1 is involved in abnormal scar formation by dermal fibroblasts through RhoA/Rho‐kinase pathwayExperimental Dermatology, 2017
- Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic SclerosisJournal of Scleroderma and Related Disorders, 2017
- Meta-analysis of circulating adiponectin, leptin, and resistin levels in systemic sclerosisZeitschrift für Rheumatologie, 2016
- Serum adipokines levels in patients with systemic sclerosis: A meta-analysisModern Rheumatology, 2016
- Current and future direction in the management of sclerodermaArchives of Dermatological Research, 2016
- Endothelin Receptors Expressed by Immune Cells Are Involved in Modulation of Inflammation and in Fibrosis: Relevance to the Pathogenesis of Systemic SclerosisJournal of Immunology Research, 2015
- Relationship between serum leptin level and disease activity in patients with systemic sclerosisClinical Rheumatology, 2013
- Resistin Promotes Endothelial Cell ActivationCirculation, 2003
- Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injuryJournal of Neuroimmunology, 2002